Weiyu Ye

1.4k total citations · 1 hit paper
24 papers, 806 citations indexed

About

Weiyu Ye is a scholar working on Rheumatology, Immunology and Physiology. According to data from OpenAlex, Weiyu Ye has authored 24 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 9 papers in Immunology and 7 papers in Physiology. Recurrent topics in Weiyu Ye's work include Spondyloarthritis Studies and Treatments (9 papers), Autoimmune and Inflammatory Disorders Research (6 papers) and Psoriasis: Treatment and Pathogenesis (5 papers). Weiyu Ye is often cited by papers focused on Spondyloarthritis Studies and Treatments (9 papers), Autoimmune and Inflammatory Disorders Research (6 papers) and Psoriasis: Treatment and Pathogenesis (5 papers). Weiyu Ye collaborates with scholars based in United Kingdom, United States and New Zealand. Weiyu Ye's co-authors include Jamie Hartmann‐Boyce, Chris Bullen, Tim Lancaster, Thomas Fanshawe, Nicola Lindson, Laura C. Coates, Laura Tucker, Deepak R. Jadon, Carmel B. Stober and Gavin Clunie and has published in prestigious journals such as Journal of the American College of Cardiology, Cochrane Database of Systematic Reviews and European Heart Journal.

In The Last Decade

Weiyu Ye

22 papers receiving 783 citations

Hit Papers

Nicotine replacement therapy versus control for smoking c... 2018 2026 2020 2023 2018 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiyu Ye United Kingdom 9 503 159 152 136 105 24 806
Ying Qin China 15 198 0.4× 101 0.6× 122 0.8× 96 0.7× 19 0.2× 47 723
Jingmin Liu United States 16 289 0.6× 176 1.1× 63 0.4× 70 0.5× 12 0.1× 27 694
Drew Payne United Kingdom 13 238 0.5× 115 0.7× 67 0.4× 45 0.3× 26 0.2× 72 643
Jennifer Ose United States 11 253 0.5× 170 1.1× 68 0.4× 31 0.2× 18 0.2× 38 580
Vanessa Clark Australia 16 653 1.3× 51 0.3× 92 0.6× 50 0.4× 8 0.1× 41 1.0k
T. Li United States 9 127 0.3× 209 1.3× 34 0.2× 13 0.1× 76 0.7× 15 746
Caroline Signore United States 20 68 0.1× 331 2.1× 120 0.8× 12 0.1× 237 2.3× 32 1.4k
Huilin Cheng Hong Kong 19 206 0.4× 160 1.0× 41 0.3× 37 0.3× 57 0.5× 80 1.1k
Sarah D. Mills United States 14 162 0.3× 92 0.6× 27 0.2× 28 0.2× 36 0.3× 50 640
Aurel O. Iuga United States 7 74 0.1× 28 0.2× 61 0.4× 28 0.2× 80 0.8× 8 800

Countries citing papers authored by Weiyu Ye

Since Specialization
Citations

This map shows the geographic impact of Weiyu Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyu Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyu Ye more than expected).

Fields of papers citing papers by Weiyu Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiyu Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyu Ye. The network helps show where Weiyu Ye may publish in the future.

Co-authorship network of co-authors of Weiyu Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Weiyu Ye. A scholar is included among the top collaborators of Weiyu Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiyu Ye. Weiyu Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Weiyu, et al.. (2025). Exploring the dynamic responses of group 3 innate lymphoid cells at different times in response to LPS challenge. International Immunopharmacology. 148. 114162–114162. 1 indexed citations
2.
Borlaug, Barry A., Michael R. Zile, Christopher M. Kramer, et al.. (2025). Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of Tirzepatide in HFpEF. Journal of the American College of Cardiology. 86(4). 242–255. 5 indexed citations
3.
Borlaug, Barry A., Michael R. Zile, Christopher M. Kramer, et al.. (2025). HFpEF-ABA score is a more useful enrichment tool than natriuretic peptides in heart failure with preserved ejection fraction. European Heart Journal. 46(43). 4607–4609. 1 indexed citations
5.
Wang, Min, Weiyu Ye, Kun Zhang, et al.. (2025). The mechanism of electroacupuncture-mediated improvement in Parkinson’s disease by inhibiting ferroptosis through activating the Nrf2/GPX4 signal pathway. Frontiers in Aging Neuroscience. 17. 1551404–1551404.
6.
Chandler, Julie, Urvi Desai, Nicolae Done, et al.. (2024). Impact of Differential Rates of Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Findings from a Longitudinal Cohort Analysis. The Journal of Prevention of Alzheimer s Disease. 11(2). 320–328. 3 indexed citations
7.
Ye, Weiyu, Chelsea Taylor, Rosalin Cooper, et al.. (2024). Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination. Journal for ImmunoTherapy of Cancer. 12(4). e008151–e008151. 2 indexed citations
8.
Chandler, Julie, et al.. (2024). Potential Implications of Slowing Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Estimates from Real-World Data. The Journal of Prevention of Alzheimer s Disease. 11(2). 310–319. 2 indexed citations
10.
Ye, Weiyu, Anna Olsson‐Brown, Robert Watson, et al.. (2021). Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles. British Journal of Cancer. 124(10). 1661–1669. 33 indexed citations
11.
Ye, Weiyu, et al.. (2020). Comparing the Visual Analog Scale and the Numerical Rating Scale in Patient-reported Outcomes in Psoriatic Arthritis. The Journal of Rheumatology. 48(6). 836–840. 7 indexed citations
12.
Eagle, Dawn M., et al.. (2020). Dissociable dopaminergic and pavlovian influences in goal-trackers and sign-trackers on a model of compulsive checking in OCD. Psychopharmacology. 237(12). 3569–3581. 7 indexed citations
13.
Cheung, Vincent, Tarun Gupta, Weiyu Ye, et al.. (2019). PTU-061 Immunotherapy-related gastritis in a tertiary oncology centre. A147.2–A147. 6 indexed citations
14.
Ye, Weiyu & Laura C. Coates. (2019). Should Methotrexate Have Any Place in the Treatment of Psoriatic Arthritis?. Rheumatic Disease Clinics of North America. 45(3). 325–339. 8 indexed citations
15.
Hartmann‐Boyce, Jamie, et al.. (2018). Nicotine replacement therapy versus control for smoking cessation. Cochrane Database of Systematic Reviews. 2019(1). CD000146–CD000146. 428 indexed citations breakdown →
16.
Tucker, Laura, Weiyu Ye, & Laura C. Coates. (2018). Novel Concepts in Psoriatic Arthritis Management: Can We Treat to Target?. Current Rheumatology Reports. 20(11). 71–71. 20 indexed citations
17.
Ye, Weiyu, Laura Tucker, & Laura C. Coates. (2018). Tapering and Discontinuation of Biologics in Patients with Psoriatic Arthritis with Low Disease Activity. Drugs. 78(16). 1705–1715. 25 indexed citations
18.
Stober, Carmel B., et al.. (2017). Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritis. Lara D. Veeken. 57(1). 158–163. 53 indexed citations
19.
Ye, Weiyu, et al.. (2017). Refractory Rheumatoid Arthritis and Associated Interstitial Lung Disease. JCR Journal of Clinical Rheumatology. 23(2). 125–126. 3 indexed citations
20.
Ye, Weiyu, et al.. (2015). Successful tocilizumab desensitization in an adult with juvenile idiopathic arthritis. Scandinavian Journal of Rheumatology. 45(1). 75–76. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026